Skip Page Header

Home > Frequently asked questions on opioid agonist treatment for pharmaceutical opioid dependence: An evidence summary.

Nielsen, Suzanne [NDARC] . (2017) Frequently asked questions on opioid agonist treatment for pharmaceutical opioid dependence: An evidence summary. Sydney: National Drug and Alcohol Research Centre. 16 p.

[img]
Preview
PDF (Frequently asked questions on opioid agonist treatment for pharmaceutical opioid dependence)
106kB

This evidence summary from Australia comes from a program of work that aimed to build the evidence base for the treatment of pharmaceutical opioid dependence, or dependence on opioid pain medications such as oxycodone, morphine and codeine. Many of the original trials examining methadone and buprenorphine (+/- naloxone) were conducted in people dependent on heroin. In recent years new studies and revised analysis from older studies have aimed to provide information on the use of methadone and buprenorphine (+ naloxone) for those dependent on pharmaceutical opioids such as codeine, morphine and oxycodone. This document is a summary of key findings in a ‘frequently asked questions’ format.


Repository Staff Only: item control page